Showing results (51-60 of 242) with videos related to
Sort By:
Pageof 25
Nature Protocols|January 5, 2018
Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantationJatin Roper, Tuomas Tammela, Adam Akkad, et al.Journal of Pediatric Hematology/Oncology|August 7, 2003
Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigationMargaret E McLaughlin, Caroline D Robson, Mark W Kieran, et al.Nature Medicine|December 28, 2004
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancerDaniela M Dinulescu, Tan A Ince, Bradley J Quade, et al.Nature|April 5, 2002
p63 and p73 are required for p53-dependent apoptosis in response to DNA damageElsa R Flores, Kenneth Y Tsai, Denise Crowley, et al.Nucleic Acids Research|January 6, 2004
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insultEmily E Bosco, Christopher N Mayhew, Robert F Hennigan, et al.Oncogene|July 12, 2005
Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferationRobin Kuns, Joseph L Kissil, Irene F Newsham, et al.Current Biology : CB|November 15, 2003
Perp is a mediator of p53-dependent apoptosis in diverse cell typesRebecca A Ihrie, Elizabeth Reczek, Jennifer S Horner, et al.Cell|May 7, 2016
Lung Adenocarcinoma Distally Rewires Hepatic Circadian HomeostasisSelma Masri, Thales Papagiannakopoulos, Kenichiro Kinouchi, et al.Cancer Research|November 17, 2005
The differential effects of mutant p53 alleles on advanced murine lung cancerErica L Jackson, Kenneth P Olive, David A Tuveson, et al.Cancer Discovery|August 30, 2011
Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinomaWen Xue, Etienne Meylan, Trudy G Oliver, et al.Pageof 25